virus known scientific pvsripo infused directly brains reach tumor duke doctors planned gradually increase dose study higher doses patients began experiencing brain swelling resulted seizures cognitive disturbances researchers retreated lower safer dose therapy eventually majority patients study 61 treated patients median overall survival 12.5 months study lacked true control arm comparison duke combed medical records past patients compile group 104 type recurrent glioblastoma median overall survival historical control group 11.3 months difference median survival slightly month favored poliovirus therapy historical control not statistically significant researchers performed analysis determine percentage patients alive certain time points year 54 percent poliovirus patients alive